Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis
Clinical trial NCT01860170 · COMPLETED
Trial details
- NCT number
- NCT01860170
- Sponsor
- Corewell Health West
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2016-03-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.